Jan Delabie

Publications by Jan Delabie

168 publications found

Publications 2013

1. Chiorazzi M, Rui L, Yang Y, Ceribelli M, Tishbi N, Maurer CW, Ranuncolo SM, Zhao H, Xu W, Chan WC, Jaffe ES, Gascoyne RD, Campo E, Rosenwald A, Ott G, Delabie J, Rimsza LM, Shaham S, Staudt LM (2013)
   Related F-box proteins control cell death in Caenorhabditis elegans and human lymphoma
   Proc Natl Acad Sci U S A, 110 (10), 3943-8
   PubMed 23431138
2. Holte H, Leppä S, Björkholm M, Fluge O, Jyrkkiö S, Delabie J, Sundström C, Karjalainen-Lindsberg ML, Erlanson M, Kolstad A, Fosså A, Ostenstad B, Löfvenberg E, Nordström M, Janes R, Pedersen LM, Anderson H, Jerkeman M, Eriksson M (2013)
   Dose-densified chemoimmunotherapy followed by systemic central nervous system prophylaxis for younger high-risk diffuse large B-cell/follicular grade 3 lymphoma patients: results of a phase II Nordic Lymphoma Group study
   Ann Oncol, 24 (5), 1385-92
   PubMed 23247661
3. Mantaka P, Helsing P, Gjersvik P, Bassarova A, Clausen OP, Delabie J (2013)
   Clinical and histopathological features of folliculotropic mycosis fungoides: a norwegian patient series
   Acta Derm Venereol, 93 (3), 325-9
   PubMed 23053197
4. Myklebust JH, Irish JM, Brody J, Czerwinski DK, Houot R, Kohrt HE, Timmerman J, Said J, Green MR, Delabie J, Kolstad A, Alizadeh AA, Levy R (2013)
   High PD-1 expression and suppressed cytokine signaling distinguish T cells infiltrating follicular lymphoma tumors from peripheral T cells
   Blood, 121 (8), 1367-76
   PubMed 23297127
5. Randen U, Tierens AM, Tjønnfjord GE, Delabie J (2013)
   Bone marrow histology in monoclonal B-cell lymphocytosis shows various B-cell infiltration patterns
   Am J Clin Pathol, 139 (3), 390-5
   PubMed 23429376
6. Trøen G, Warsame A, Delabie J (2013)
   CD79B and MYD88 Mutations in Splenic Marginal Zone Lymphoma
   ISRN Oncol, 2013, 252318
   PubMed 23378931
7. Valentino C, Kendrick S, Johnson N, Gascoyne R, Chan WC, Weisenburger D, Braziel R, Cook JR, Tubbs R, Campo E, Rosenwald A, Ott G, Delabie J, Jaffe E, Zhang W, Brunhoeber P, Nitta H, Grogan T, Rimsza L (2013)
   Colorimetric in situ hybridization identifies MYC gene signal clusters correlating with increased copy number, mRNA, and protein in diffuse large B-cell lymphoma
   Am J Clin Pathol, 139 (2), 242-54
   PubMed 23355209

Publications 2012

1. Blix ES, Irish JM, Husebekk A, Delabie J, Forfang L, Tierens AM, Myklebust JH, Kolstad A (2012)
   Phospho-specific flow cytometry identifies aberrant signaling in indolent B-cell lymphoma
   BMC Cancer, 12, 478
   PubMed 23072591
2. Blix ES, Irish JM, Husebekk A, Delabie J, Tierens AM, Myklebust JH, Kolstad A (2012)
   Altered BCR and CD40 signalling are associated with clinical outcome in small lymphocytic lymphoma/chronic lymphocytic leukaemia and marginal zone lymphoma patients
   Br J Haematol, 159 (5), 604-8
   PubMed 23043253
3. Carvajal-Cuenca A, Sua LF, Silva NM, Pittaluga S, Royo C, Song JY, Sargent RL, Espinet B, Climent F, Jacobs SA, Delabie J, Naresh KN, Bagg A, Brousset P, Warnke RA, Serrano S, Harris NL, Swerdlow SH, Jaffe ES, Campo E (2012)
   In situ mantle cell lymphoma: clinical implications of an incidental finding with indolent clinical behavior
   Haematologica, 97 (2), 270-8
   PubMed 22058203
4. d'Amore F, Relander T, Lauritzsen GF, Jantunen E, Hagberg H, Anderson H, Holte H, Österborg A, Merup M, Brown P, Kuittinen O, Erlanson M, Østenstad B, Fagerli UM, Gadeberg OV, Sundström C, Delabie J, Ralfkiaer E, Vornanen M, Toldbod HE (2012)
   Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01
   J Clin Oncol, 30 (25), 3093-9
   PubMed 22851556
5. Deffenbacher KE, Iqbal J, Sanger W, Shen Y, Lachel C, Liu Z, Liu Y, Lim MS, Perkins SL, Fu K, Smith L, Lynch J, Staudt LM, Rimsza LM, Jaffe E, Rosenwald A, Ott GK, Delabie J, Campo E, Gascoyne RD, Cairo MS, Weisenburger DD, Greiner TC, Gross TG, Chan WC (2012)
   Molecular distinctions between pediatric and adult mature B-cell non-Hodgkin lymphomas identified through genomic profiling
   Blood, 119 (16), 3757-66
   PubMed 22374697
6. Delabie J (2012)
   Keeping good and bad company: stromal cells in lymphoma
   Leuk Lymphoma, 53 (9), 1654-5
   PubMed 22680767
7. Geisler CH, Kolstad A, Laurell A, Jerkeman M, Raty R, Andersen NS, Pedersen LB, Eriksson M, Nordstrom M, Kimby E, Bentzen H, Kuittinen O, Lauritzsen GF, Nilsson-Ehle H, Ralfkiaer E, Ehinger M, Sundstrom C, Delabie J, Karjalainen-Lindsberg ML, Brown P, Elonen E, Nordic Lymphoma Grp (2012)
   Nordic MCL2 Trial Update: 6-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC Plus autologous stem-cell support: still very long survival but late relapses do occur (vol 158, pg 355, 2012)
   Br. J. Haematol., 158 (6), 815-816
8. Geisler CH, Kolstad A, Laurell A, Jerkeman M, Räty R, Andersen NS, Pedersen LB, Eriksson M, Nordström M, Kimby E, Bentzen H, Kuittinen O, Lauritzsen GF, Nilsson-Ehle H, Ralfkiaer E, Ehinger M, Sundström C, Delabie J, Karjalainen-Lindsberg ML, Brown P, Elonen E, Nordic Lymphoma Group (2012)
   Nordic MCL2 trial update: six-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC + autologous stem-cell support: still very long survival but late relapses do occur
   Br J Haematol, 158 (3), 355-62
   PubMed 22640180
9. Iqbal J, Shen Y, Liu Y, Fu K, Jaffe ES, Liu C, Liu Z, Lachel CM, Deffenbacher K, Greiner TC, Vose JM, Bhagavathi S, Staudt LM, Rimsza L, Rosenwald A, Ott G, Delabie J, Campo E, Braziel RM, Cook JR, Tubbs RR, Gascoyne RD, Armitage JO, Weisenburger DD, McKeithan TW et al. (2012)
   Genome-wide miRNA profiling of mantle cell lymphoma reveals a distinct subgroup with poor prognosis
   Blood, 119 (21), 4939-48
   PubMed 22490335
10. Johnson NA, Slack GW, Savage KJ, Connors JM, Ben-Neriah S, Rogic S, Scott DW, Tan KL, Steidl C, Sehn LH, Chan WC, Iqbal J, Meyer PN, Lenz G, Wright G, Rimsza LM, Valentino C, Brunhoeber P, Grogan TM, Braziel RM, Cook JR, Tubbs RR, Weisenburger DD, Campo E, Rosenwald A et al. (2012)
    Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone
    J Clin Oncol, 30 (28), 3452-9
    PubMed 22851565
11. Perry AM, Cardesa-Salzmann TM, Meyer PN, Colomo L, Smith LM, Fu K, Greiner TC, Delabie J, Gascoyne RD, Rimsza L, Jaffe ES, Ott G, Rosenwald A, Braziel RM, Tubbs R, Cook JR, Staudt LM, Connors JM, Sehn LH, Vose JM, López-Guillermo A, Campo E, Chan WC, Weisenburger DD (2012)
    A new biologic prognostic model based on immunohistochemistry predicts survival in patients with diffuse large B-cell lymphoma
    Blood, 120 (11), 2290-6
    PubMed 22740447
12. Schmitz R, Young RM, Ceribelli M, Jhavar S, Xiao W, Zhang M, Wright G, Shaffer AL, Hodson DJ, Buras E, Liu X, Powell J, Yang Y, Xu W, Zhao H, Kohlhammer H, Rosenwald A, Kluin P, Müller-Hermelink HK, Ott G, Gascoyne RD, Connors JM, Rimsza LM, Campo E, Jaffe ES et al. (2012)
    Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics
    Nature, 490 (7418), 116-20
    PubMed 22885699
13. Wahlin BE, Yri OE, Kimby E, Holte H, Delabie J, Smeland EB, Sundström C, Christensson B, Sander B (2012)
    Clinical significance of the WHO grades of follicular lymphoma in a population-based cohort of 505 patients with long follow-up times
    Br J Haematol, 156 (2), 225-33
    PubMed 22126847
14. Warsame A, Delabie J, Malecka A, Wang J, Trøen G, Tierens A (2012)
    Monocytoid B cells: an enigmatic B cell subset showing evidence of extrafollicular immunoglobulin gene somatic hypermutation
    Scand J Immunol, 75 (5), 500-9
    PubMed 22486786

Publications 2011

1. Cardesa-Salzmann TM, Colomo L, Gutierrez G, Chan WC, Weisenburger D, Climent F, González-Barca E, Mercadal S, Arenillas L, Serrano S, Tubbs R, Delabie J, Gascoyne RD, Connors JM, Mate JL, Rimsza L, Braziel R, Rosenwald A, Lenz G, Wright G, Jaffe ES, Staudt L, Jares P, López-Guillermo A, Campo E (2011)
   High microvessel density determines a poor outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus chemotherapy
   Haematologica, 96 (7), 996-1001
   PubMed 21546504
2. Delabie J, Brodtkorb-Eide M (2011)
   Diffuse large B-cell lymphoma cycling off the main track
   Leuk Lymphoma, 52 (3), 358-9
   PubMed 21323518
3. Delabie J, Holte H, Vose JM, Ullrich F, Jaffe ES, Savage KJ, Connors JM, Rimsza L, Harris NL, Müller-Hermelink K, Rüdiger T, Coiffier B, Gascoyne RD, Berger F, Tobinai K, Au WY, Liang R, Montserrat E, Hochberg EP, Pileri S, Federico M, Nathwani B, Armitage JO, Weisenburger DD (2011)
   Enteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma project
   Blood, 118 (1), 148-55
   PubMed 21566094
4. Eide MB, Lauritzsen GF, Kvalheim G, Kolstad A, Fagerli UM, Maisenhölder M, Østenstad B, Fluge Ø, Delabie J, Aarset H, Liestøl K, Holte H (2011)
   High dose chemotherapy with autologous stem cell support for patients with histologically transformed B-cell non-Hodgkin lymphomas. A Norwegian multi centre phase II study
   Br J Haematol, 152 (5), 600-10
   PubMed 21241276
5. Fløisand Y, Delabie J, Fosså A, Helseth E, Jacobsen EA, Rolke J, Tjønnfjord GE (2011)
   Richter syndrome presenting as a solitary cerebellar tumor during first-line treatment for chronic lymphocytic leukemia
   Leuk Lymphoma, 52 (10), 2007-9
   PubMed 21663503
6. Iqbal J, Meyer PN, Smith LM, Johnson NA, Vose JM, Greiner TC, Connors JM, Staudt LM, Rimsza L, Jaffe E, Rosenwald A, Ott G, Delabie J, Campo E, Braziel RM, Cook JR, Tubbs RR, Gascoyne RD, Armitage JO, Weisenburger DD, Chan WC (2011)
   BCL2 predicts survival in germinal center B-cell-like diffuse large B-cell lymphoma treated with CHOP-like therapy and rituximab
   Clin Cancer Res, 17 (24), 7785-95
   PubMed 21933893
7. Iqbal J, Weisenburger DD, Chowdhury A, Tsai MY, Srivastava G, Greiner TC, Kucuk C, Deffenbacher K, Vose J, Smith L, Au WY, Nakamura S, Seto M, Delabie J, Berger F, Loong F, Ko YH, Sng I, Liu X, Loughran TP, Armitage J, Chan WC, International Peripheral T-cell Lymphoma Project (2011)
   Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic ?? T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro
   Leukemia, 25 (2), 348-58
   PubMed 21052088
8. Leich E, Zamo A, Horn H, Haralambieva E, Puppe B, Gascoyne RD, Chan WC, Braziel RM, Rimsza LM, Weisenburger DD, Delabie J, Jaffe ES, Fitzgibbon J, Staudt LM, Mueller-Hermelink HK, Calaminici M, Campo E, Ott G, Hernández L, Rosenwald A (2011)
   MicroRNA profiles of t(14;18)-negative follicular lymphoma support a late germinal center B-cell phenotype
   Blood, 118 (20), 5550-8
   PubMed 21960592
9. Meyer PN, Fu K, Greiner T, Smith L, Delabie J, Gascoyne R, Ott G, Rosenwald A, Braziel R, Campo E, Vose J, Lenz G, Staudt L, Chan W, Weisenburger DD (2011)
   The stromal cell marker SPARC predicts for survival in patients with diffuse large B-cell lymphoma treated with rituximab
   Am J Clin Pathol, 135 (1), 54-61
   PubMed 21173124
10. Meyer PN, Fu K, Greiner TC, Smith LM, Delabie J, Gascoyne RD, Ott G, Rosenwald A, Braziel RM, Campo E, Vose JM, Lenz G, Staudt LM, Chan WC, Weisenburger DD (2011)
    Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab
    J Clin Oncol, 29 (2), 200-7
    PubMed 21135273
11. Ngo VN, Young RM, Schmitz R, Jhavar S, Xiao W, Lim KH, Kohlhammer H, Xu W, Yang Y, Zhao H, Shaffer AL, Romesser P, Wright G, Powell J, Rosenwald A, Muller-Hermelink HK, Ott G, Gascoyne RD, Connors JM, Rimsza LM, Campo E, Jaffe ES, Delabie J, Smeland EB, Fisher RI et al. (2011)
    Oncogenically active MYD88 mutations in human lymphoma
    Nature, 470 (7332), 115-9
    PubMed 21179087
12. Rimsza LM, Wright G, Schwartz M, Chan WC, Jaffe ES, Gascoyne RD, Campo E, Rosenwald A, Ott G, Cook JR, Tubbs RR, Braziel RM, Delabie J, Miller TP, Staudt LM (2011)
    Accurate classification of diffuse large B-cell lymphoma into germinal center and activated B-cell subtypes using a nuclease protection assay on formalin-fixed, paraffin-embedded tissues
    Clin Cancer Res, 17 (11), 3727-32
    PubMed 21364035
13. Warsame AA, Aasheim HC, Nustad K, Trøen G, Tierens A, Wang V, Randen U, Dong HP, Heim S, Brech A, Delabie J (2011)
    Splenic marginal zone lymphoma with VH1-02 gene rearrangement expresses poly- and self-reactive antibodies with similar reactivity
    Blood, 118 (12), 3331-9
    PubMed 21725051

Publications 2010

1. Davis RE, Ngo VN, Lenz G, Tolar P, Young RM, Romesser PB, Kohlhammer H, Lamy L, Zhao H, Yang Y, Xu W, Shaffer AL, Wright G, Xiao W, Powell J, Jiang JK, Thomas CJ, Rosenwald A, Ott G, Muller-Hermelink HK, Gascoyne RD, Connors JM, Johnson NA, Rimsza LM, Campo E et al. (2010)
   Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma
   Nature, 463 (7277), 88-92
   PubMed 20054396
2. Delabie J (2010)
   Prognostic markers in diffuse large B-cell lymphoma
   Leuk Lymphoma, 51 (9), 1588-9
   PubMed 20807090
3. Eide MB, Liestøl K, Lingjaerde OC, Hystad ME, Kresse SH, Meza-Zepeda L, Myklebost O, Trøen G, Aamot HV, Holte H, Smeland EB, Delabie J (2010)
   Genomic alterations reveal potential for higher grade transformation in follicular lymphoma and confirm parallel evolution of tumor cell clones
   Blood, 116 (9), 1489-97
   PubMed 20505157
4. Geisler CH, Kolstad A, Laurell A, Räty R, Jerkeman M, Eriksson M, Nordström M, Kimby E, Boesen AM, Nilsson-Ehle H, Kuittinen O, Lauritzsen GF, Ralfkiaer E, Ehinger M, Sundström C, Delabie J, Karjalainen-Lindsberg ML, Brown P, Elonen E, Nordic Lymphoma Group (2010)
   The Mantle Cell Lymphoma International Prognostic Index (MIPI) is superior to the International Prognostic Index (IPI) in predicting survival following intensive first-line immunochemotherapy and autologous stem cell transplantation (ASCT)
   Blood, 115 (8), 1530-3
   PubMed 20032504
5. Hartmann EM, Campo E, Wright G, Lenz G, Salaverria I, Jares P, Xiao W, Braziel RM, Rimsza LM, Chan WC, Weisenburger DD, Delabie J, Jaffe ES, Gascoyne RD, Dave SS, Mueller-Hermelink HK, Staudt LM, Ott G, Beà S, Rosenwald A (2010)
   Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling
   Blood, 116 (6), 953-61
   PubMed 20421449
6. Iqbal J, Weisenburger DD, Greiner TC, Vose JM, McKeithan T, Kucuk C, Geng H, Deffenbacher K, Smith L, Dybkaer K, Nakamura S, Seto M, Delabie J, Berger F, Loong F, Au WY, Ko YH, Sng I, Armitage JO, Chan WC, International Peripheral T-Cell Lymphoma Project (2010)
   Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma
   Blood, 115 (5), 1026-36
   PubMed 19965671
7. Majak BM, Delabie J, Soland T (2010)
   Malignant lymphoma of the tongue with unusual cytology in a pleural effusion: a case report
   Acta Cytol, 54 (4), 645-8
   PubMed 20715672
8. Rui L, Emre NC, Kruhlak MJ, Chung HJ, Steidl C, Slack G, Wright GW, Lenz G, Ngo VN, Shaffer AL, Xu W, Zhao H, Yang Y, Lamy L, Davis RE, Xiao W, Powell J, Maloney D, Thomas CJ, Möller P, Rosenwald A, Ott G, Muller-Hermelink HK, Savage K, Connors JM et al. (2010)
   Cooperative epigenetic modulation by cancer amplicon genes
   Cancer Cell, 18 (6), 590-605
   PubMed 21156283
9. Steidl C, Lee T, Shah SP, Farinha P, Han G, Nayar T, Delaney A, Jones SJ, Iqbal J, Weisenburger DD, Bast MA, Rosenwald A, Muller-Hermelink HK, Rimsza LM, Campo E, Delabie J, Braziel RM, Cook JR, Tubbs RR, Jaffe ES, Lenz G, Connors JM, Staudt LM, Chan WC, Gascoyne RD (2010)
   Tumor-associated macrophages and survival in classic Hodgkin's lymphoma
   N Engl J Med, 362 (10), 875-85
   PubMed 20220182
10. Tauro S, Cochrane L, Lauritzsen GF, Baker L, Delabie J, Roberts C, Mahendra P, Holte H (2010)
    Dose-intensified treatment of Burkitt lymphoma and B-cell lymphoma unclassifiable, (with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma) in young adults (<50 years): a comparison of two adapted BFM protocols
    Am J Hematol, 85 (4), 261-3
    PubMed 20201088
11. Tierens AM, Holte H, Warsame A, Ikonomou IM, Wang J, Chan WC, Delabie J (2010)
    Low levels of monoclonal small B cells in the bone marrow of patients with diffuse large B-cell lymphoma of activated B-cell type but not of germinal center B-cell type
    Haematologica, 95 (8), 1334-41
    PubMed 20145271
12. Valera A, Balagué O, Colomo L, Martínez A, Delabie J, Taddesse-Heath L, Jaffe ES, Campo E (2010)
    IG/MYC rearrangements are the main cytogenetic alteration in plasmablastic lymphomas
    Am J Surg Pathol, 34 (11), 1686-94
    PubMed 20962620
13. Van Loo P, Tousseyn T, Vanhentenrijk V, Dierickx D, Malecka A, Vanden Bempt I, Verhoef G, Delabie J, Marynen P, Matthys P, De Wolf-Peeters C (2010)
    T-cell/histiocyte-rich large B-cell lymphoma shows transcriptional features suggestive of a tolerogenic host immune response
    Haematologica, 95 (3), 440-8
    PubMed 19797726
14. Van Roosbroeck K, Cools J, Dierickx D, Thomas J, Vandenberghe P, Stul M, Delabie J, De Wolf-Peeters C, Marynen P, Wlodarska I (2010)
    ALK-positive large B-cell lymphomas with cryptic SEC31A-ALK and NPM1-ALK fusions
    Haematologica, 95 (3), 509-13
    PubMed 20207848

Publications 2009

1. Bassarova A, Trøen G, Fosså A, Ikonomou IM, Beiske K, Nesland JM, Delabie J (2009)
   Transformation of B cell lymphoma to histiocytic sarcoma: somatic mutations of PAX-5 gene with loss of expression cannot explain transdifferentiation
   J Hematop, 2 (3), 135-41
   PubMed 19669194
2. Choi WW, Weisenburger DD, Greiner TC, Piris MA, Banham AH, Delabie J, Braziel RM, Geng H, Iqbal J, Lenz G, Vose JM, Hans CP, Fu K, Smith LM, Li M, Liu Z, Gascoyne RD, Rosenwald A, Ott G, Rimsza LM, Campo E, Jaffe ES, Jaye DL, Staudt LM, Chan WC (2009)
   A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy
   Clin Cancer Res, 15 (17), 5494-502
   PubMed 19706817
3. Holte H, Kvaløy S, Delabie J, Trøen G, Smeland EB (2009)
   [Molecular diagnosis of malignant lymphomas]
   Tidsskr Nor Laegeforen, 129 (22), 2352-6
   PubMed 19935935
4. Leich E, Salaverria I, Bea S, Zettl A, Wright G, Moreno V, Gascoyne RD, Chan WC, Braziel RM, Rimsza LM, Weisenburger DD, Delabie J, Jaffe ES, Lister A, Fitzgibbon J, Staudt LM, Hartmann EM, Mueller-Hermelink HK, Campo E, Ott G, Rosenwald A (2009)
   Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations
   Blood, 114 (4), 826-34
   PubMed 19471018
5. Mozos A, Royo C, Hartmann E, De Jong D, Baró C, Valera A, Fu K, Weisenburger DD, Delabie J, Chuang SS, Jaffe ES, Ruiz-Marcellan C, Dave S, Rimsza L, Braziel R, Gascoyne RD, Solé F, López-Guillermo A, Colomer D, Staudt LM, Rosenwald A, Ott G, Jares P, Campo E (2009)
   SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype
   Haematologica, 94 (11), 1555-62
   PubMed 19880778
6. Rimsza LM, Chan WC, Gascoyne RD, Campo E, Jaffe ES, Staudt LM, Delabie J, Rosenwald A, Murphy SP (2009)
   CIITA or RFX coding region loss of function mutations occur rarely in diffuse large B-cell lymphoma cases and cell lines with low levels of major histocompatibility complex class II expression
   Haematologica, 94 (4), 596-8
   PubMed 19229048
7. Wilkinson ST, Fernandez DR, Murphy SP, Braziel RM, Campo E, Chan WC, Delabie J, Gascoyne RD, Staudt LM, Jaffe ES, Rosenwald A, Rimsza LM (2009)
   Decreased major histocompatibility complex class II expression in diffuse large B-cell lymphoma does not correlate with CpG methylation of class II transactivator promoters III and IV
   Leuk Lymphoma, 50 (11), 1875-8
   PubMed 19814686

Publications 2008

1. Bassarova A, Tierens A, Lauritzsen GF, Fosså A, Delabie J (2008)
   Mantle cell lymphoma with partial involvement of the mantle zone: an early infiltration pattern of mantle cell lymphoma?
   Virchows Arch, 453 (4), 407-11
   PubMed 18696109
2. Geisler CH, Kolstad A, Laurell A, Andersen NS, Pedersen LB, Jerkeman M, Eriksson M, Nordström M, Kimby E, Boesen AM, Kuittinen O, Lauritzsen GF, Nilsson-Ehle H, Ralfkiaer E, Akerman M, Ehinger M, Sundström C, Langholm R, Delabie J, Karjalainen-Lindsberg ML, Brown P, Elonen E, Nordic Lymphoma Group (2008)
   Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo-purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group
   Blood, 112 (7), 2687-93
   PubMed 18625886
3. Ikdahl T, Josefsen D, Jakobsen E, Delabie J, Fosså SD (2008)
   Concurrent mediastinal germ-cell tumour and haematological malignancy: case report and short review of literature
   Acta Oncol, 47 (3), 466-9
   PubMed 18348004
4. Lenz G, Davis RE, Ngo VN, Lam L, George TC, Wright GW, Dave SS, Zhao H, Xu W, Rosenwald A, Ott G, Muller-Hermelink HK, Gascoyne RD, Connors JM, Rimsza LM, Campo E, Jaffe ES, Delabie J, Smeland EB, Fisher RI, Chan WC, Staudt LM (2008)
   Oncogenic CARD11 mutations in human diffuse large B cell lymphoma
   Science, 319 (5870), 1676-9
   PubMed 18323416
5. Lenz G, Wright G, Dave SS, Xiao W, Powell J, Zhao H, Xu W, Tan B, Goldschmidt N, Iqbal J, Vose J, Bast M, Fu K, Weisenburger DD, Greiner TC, Armitage JO, Kyle A, May L, Gascoyne RD, Connors JM, Troen G, Holte H, Kvaloy S, Dierickx D, Verhoef G et al. (2008)
   Stromal gene signatures in large-B-cell lymphomas
   N Engl J Med, 359 (22), 2313-23
   PubMed 19038878
6. Lenz G, Wright GW, Emre NC, Kohlhammer H, Dave SS, Davis RE, Carty S, Lam LT, Shaffer AL, Xiao W, Powell J, Rosenwald A, Ott G, Muller-Hermelink HK, Gascoyne RD, Connors JM, Campo E, Jaffe ES, Delabie J, Smeland EB, Rimsza LM, Fisher RI, Weisenburger DD, Chan WC, Staudt LM (2008)
   Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways
   Proc Natl Acad Sci U S A, 105 (36), 13520-5
   PubMed 18765795
7. Pike BL, Greiner TC, Wang X, Weisenburger DD, Hsu YH, Renaud G, Wolfsberg TG, Kim M, Weisenberger DJ, Siegmund KD, Ye W, Groshen S, Mehrian-Shai R, Delabie J, Chan WC, Laird PW, Hacia JG (2008)
   DNA methylation profiles in diffuse large B-cell lymphoma and their relationship to gene expression status
   Leukemia, 22 (5), 1035-43
   PubMed 18288132
8. Salaverria I, Zettl A, Beà S, Hartmann EM, Dave SS, Wright GW, Boerma EJ, Kluin PM, Ott G, Chan WC, Weisenburger DD, Lopez-Guillermo A, Gascoyne RD, Delabie J, Rimsza LM, Braziel RM, Jaffe ES, Staudt LM, Müller-Hermelink HK, Campo E, Rosenwald A, Leukemia and Lymphoma Molecular Profiling Project (LLMPP) (2008)
   Chromosomal alterations detected by comparative genomic hybridization in subgroups of gene expression-defined Burkitt's lymphoma
   Haematologica, 93 (9), 1327-34
   PubMed 18698080
9. Trøen G, Wlodarska I, Warsame A, Hernández Llodrà S, De Wolf-Peeters C, Delabie J (2008)
   NOTCH2 mutations in marginal zone lymphoma
   Haematologica, 93 (7), 1107-9
   PubMed 18508802
10. Young KH, Leroy K, Møller MB, Colleoni GW, Sánchez-Beato M, Kerbauy FR, Haioun C, Eickhoff JC, Young AH, Gaulard P, Piris MA, Oberley TD, Rehrauer WM, Kahl BS, Malter JS, Campo E, Delabie J, Gascoyne RD, Rosenwald A, Rimsza L, Huang J, Braziel RM, Jaffe ES, Wilson WH, Staudt LM et al. (2008)
    Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study
    Blood, 112 (8), 3088-98
    PubMed 18559976

Publications 2007

1. Davies AJ, Rosenwald A, Wright G, Lee A, Last KW, Weisenburger DD, Chan WC, Delabie J, Braziel RM, Campo E, Gascoyne RD, Jaffe ES, Muller-Hermelink K, Ott G, Calaminici M, Norton AJ, Goff LK, Fitzgibbon J, Staudt LM, Andrew Lister T (2007)
   Transformation of follicular lymphoma to diffuse large B-cell lymphoma proceeds by distinct oncogenic mechanisms
   Br J Haematol, 136 (2), 286-93
   PubMed 17278262
2. Ikonomou IM, Aamot HV, Heim S, Fosså A, Delabie J (2007)
   Granulomatous slack skin with a translocation t(3;9)(q12;p24)
   Am J Surg Pathol, 31 (5), 803-6
   PubMed 17460466
3. Iqbal J, Greiner TC, Patel K, Dave BJ, Smith L, Ji J, Wright G, Sanger WG, Pickering DL, Jain S, Horsman DE, Shen Y, Fu K, Weisenburger DD, Hans CP, Campo E, Gascoyne RD, Rosenwald A, Jaffe ES, Delabie J, Rimsza L, Ott G, Müller-Hermelink HK, Connors JM, Vose JM et al. (2007)
   Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma
   Leukemia, 21 (11), 2332-43
   PubMed 17625604
4. Kimm LR, deLeeuw RJ, Savage KJ, Rosenwald A, Campo E, Delabie J, Ott G, Muller-Hermelink HK, Jaffe ES, Rimsza LM, Weisenburger DD, Chan WC, Staudt LM, Connors JM, Gascoyne RD, Lam WL (2007)
   Frequent occurrence of deletions in primary mediastinal B-cell lymphoma
   Genes Chromosomes Cancer, 46 (12), 1090-7
   PubMed 17823928
5. Kolstad A, Nome O, Delabie J, Lauritzsen GF, Fossa A, Holte H (2007)
   Standard CHOP-21 as first line therapy for elderly patients with Hodgkin's lymphoma
   Leuk Lymphoma, 48 (3), 570-6
   PubMed 17454601
6. Micci F, Panagopoulos I, Tjønnfjord GE, Kolstad A, Delabie J, Beiske K, Heim S (2007)
   Molecular cytogenetic characterization of t(14;19)(q32;p13), a new recurrent translocation in B cell malignancies
   Virchows Arch, 450 (5), 559-65
   PubMed 17406891
7. Salaverria I, Zettl A, Beà S, Moreno V, Valls J, Hartmann E, Ott G, Wright G, Lopez-Guillermo A, Chan WC, Weisenburger DD, Gascoyne RD, Grogan TM, Delabie J, Jaffe ES, Montserrat E, Muller-Hermelink HK, Staudt LM, Rosenwald A, Campo E (2007)
   Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signature
   J Clin Oncol, 25 (10), 1216-22
   PubMed 17296973
8. Wiestner A, Tehrani M, Chiorazzi M, Wright G, Gibellini F, Nakayama K, Liu H, Rosenwald A, Muller-Hermelink HK, Ott G, Chan WC, Greiner TC, Weisenburger DD, Vose J, Armitage JO, Gascoyne RD, Connors JM, Campo E, Montserrat E, Bosch F, Smeland EB, Kvaloy S, Holte H, Delabie J, Fisher RI et al. (2007)
   Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival
   Blood, 109 (11), 4599-606
   PubMed 17299095
9. Young KH, Weisenburger DD, Dave BJ, Smith L, Sanger W, Iqbal J, Campo E, Delabie J, Gascoyne RD, Ott G, Rimsza L, Müller-Hermelink HK, Jaffe ES, Rosenwald A, Staudt LM, Chan WC, Greiner TC (2007)
   Mutations in the DNA-binding codons of TP53, which are associated with decreased expression of TRAILreceptor-2, predict for poor survival in diffuse large B-cell lymphoma
   Blood, 110 (13), 4396-405
   PubMed 17881637

Publications 2006

1. Dave SS, Fu K, Wright GW, Lam LT, Kluin P, Boerma EJ, Greiner TC, Weisenburger DD, Rosenwald A, Ott G, Müller-Hermelink HK, Gascoyne RD, Delabie J, Rimsza LM, Braziel RM, Grogan TM, Campo E, Jaffe ES, Dave BJ, Sanger W, Bast M, Vose JM, Armitage JO, Connors JM, Smeland EB et al. (2006)
   Molecular diagnosis of Burkitt's lymphoma
   N Engl J Med, 354 (23), 2431-42
   PubMed 16760443
2. Greiner TC, Dasgupta C, Ho VV, Weisenburger DD, Smith LM, Lynch JC, Vose JM, Fu K, Armitage JO, Braziel RM, Campo E, Delabie J, Gascoyne RD, Jaffe ES, Muller-Hermelink HK, Ott G, Rosenwald A, Staudt LM, Im MY, Karaman MW, Pike BL, Chan WC, Hacia JG (2006)
   Mutation and genomic deletion status of ataxia telangiectasia mutated (ATM) and p53 confer specific gene expression profiles in mantle cell lymphoma
   Proc Natl Acad Sci U S A, 103 (7), 2352-7
   PubMed 16461462
3. Ikonomou IM, Tierens A, Troen G, Aamot HV, Heim S, Lauritzsen GF, Vålerhaugen H, Delabie J (2006)
   Peripheral T-cell lymphoma with involvement of the expanded mantle zone
   Virchows Arch, 449 (1), 78-87
   PubMed 16633785
4. Iqbal J, Neppalli VT, Wright G, Dave BJ, Horsman DE, Rosenwald A, Lynch J, Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Campo E, Ott G, Müller-Hermelink HK, Delabie J, Jaffe ES, Grogan TM, Connors JM, Vose JM, Armitage JO, Staudt LM, Chan WC (2006)
   BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphoma
   J Clin Oncol, 24 (6), 961-8
   PubMed 16418494
5. Khnykin D, Troen G, Berner JM, Delabie J (2006)
   The expression of fibroblast growth factors and their receptors in Hodgkin's lymphoma
   J Pathol, 208 (3), 431-8
   PubMed 16353171
6. Rimsza LM, Roberts RA, Campo E, Grogan TM, Bea S, Salaverria I, Zettl A, Rosenwald A, Ott G, Muller-Hermelink HK, Delabie J, Fisher RI, Unger JM, Leblanc M, Staudt LM, Jaffe ES, Gascoyne RD, Chan WC, Weisenburger DD, Greiner T, Braziel RM, Miller TP (2006)
   Loss of major histocompatibility class II expression in non-immune-privileged site diffuse large B-cell lymphoma is highly coordinated and not due to chromosomal deletions
   Blood, 107 (3), 1101-7
   PubMed 16239429
7. Aamot HV, Tjønnfjord GE, Delabie J, Heim S (2006)
   Molecular cytogenetic analysis of leukemic mantle cell lymphoma with a cryptic t(11;14)
   Cancer Genet Cytogenet, 165 (2), 172-5
   PubMed 16527613

Publications 2005

1. Bea S, Zettl A, Wright G, Salaverria I, Jehn P, Moreno V, Burek C, Ott G, Puig X, Yang L, Lopez-Guillermo A, Chan WC, Greiner TC, Weisenburger DD, Armitage JO, Gascoyne RD, Connors JM, Grogan TM, Braziel R, Fisher RI, Smeland EB, Kvaloy S, Holte H, Delabie J, Simon R et al. (2005)
   Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction
   Blood, 106 (9), 3183-90
   PubMed 16046532
2. Fu K, Weisenburger DD, Greiner TC, Dave S, Wright G, Rosenwald A, Chiorazzi M, Iqbal J, Gesk S, Siebert R, De Jong D, Jaffe ES, Wilson WH, Delabie J, Ott G, Dave BJ, Sanger WG, Smith LM, Rimsza L, Braziel RM, Müller-Hermelink HK, Campo E, Gascoyne RD, Staudt LM, Chan WC et al. (2005)
   Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling
   Blood, 106 (13), 4315-21
   PubMed 16123218
3. Hernández L, Beà S, Pinyol M, Ott G, Katzenberger T, Rosenwald A, Bosch F, López-Guillermo A, Delabie J, Colomer D, Montserrat E, Campo E (2005)
   CDK4 and MDM2 gene alterations mainly occur in highly proliferative and aggressive mantle cell lymphomas with wild-type INK4a/ARF locus
   Cancer Res, 65 (6), 2199-206
   PubMed 15781632
4. Lie AK, Risberg B, Borge B, Sandstad B, Delabie J, Rimala R, Onsrud M, Thoresen S (2005)
   DNA- versus RNA-based methods for human papillomavirus detection in cervical neoplasia
   Gynecol Oncol, 97 (3), 908-15
   PubMed 15943992
5. Patzke S, Hauge H, Sioud M, Finne EF, Sivertsen EA, Delabie J, Stokke T, Aasheim HC (2005)
   Identification of a novel centrosome/microtubule-associated coiled-coil protein involved in cell-cycle progression and spindle organization
   Oncogene, 24 (7), 1159-73
   PubMed 15580290
6. Torlakovic E, Malecka A, Myklebust JH, Tierens A, Aasheim HC, Nesland JM, Smeland E, Kvaløy S, Delabie J (2005)
   PU.1 protein expression has a positive linear association with protein expression of germinal centre B cell genes including BCL-6, CD10, CD20 and CD22: identification of PU.1 putative binding sites in the BCL-6 promotor
   J Pathol, 206 (3), 312-9
   PubMed 15892171
7. Wang J, Cheung LW, Delabie J (2005)
   New probabilistic graphical models for genetic regulatory networks studies
   J Biomed Inform, 38 (6), 443-55
   PubMed 15996532
8. Zu Y, Steinberg SM, Campo E, Hans CP, Weisenburger DD, Braziel RM, Delabie J, Gascoyne RD, Muller-Hermlink K, Pittaluga S, Raffeld M, Chan WC, Jaffe ES, Pathology Panel of the Lymphoma/Leukemia Molecular Profiling Project (2005)
   Validation of tissue microarray immunohistochemistry staining and interpretation in diffuse large B-cell lymphoma
   Leuk Lymphoma, 46 (5), 693-701
   PubMed 16019506
9. Aamot HV, Bjørnslett M, Delabie J, Heim S (2005)
   t(14;22)(q32;q11) in non-Hodgkin lymphoma and myeloid leukaemia: molecular cytogenetic investigations
   Br J Haematol, 130 (6), 845-51
   PubMed 16156854
10. Aamot HV, Micci F, Holte H, Delabie J, Heim S (2005)
    G-banding and molecular cytogenetic analyses of marginal zone lymphoma
    Br J Haematol, 130 (6), 890-901
    PubMed 16156859
11. Aasheim HC, Delabie J, Finne EF (2005)
    Ephrin-A1 binding to CD4+ T lymphocytes stimulates migration and induces tyrosine phosphorylation of PYK2
    Blood, 105 (7), 2869-76
    PubMed 15585656

Publications 2004

1. Blystad AK, Delabie J, Kvaløy S, Holte H, Vålerhaugen H, Ikonomou I, Kvalheim G (2004)
   Infused CD34 cell dose, but not tumour cell content of peripheral blood progenitor cell grafts, predicts clinical outcome in patients with diffuse large B-cell lymphoma and follicular lymphoma grade 3 treated with high-dose therapy
   Br J Haematol, 125 (5), 605-12
   PubMed 15147376
2. Dave SS, Wright G, Tan B, Rosenwald A, Gascoyne RD, Chan WC, Fisher RI, Braziel RM, Rimsza LM, Grogan TM, Miller TP, LeBlanc M, Greiner TC, Weisenburger DD, Lynch JC, Vose J, Armitage JO, Smeland EB, Kvaloy S, Holte H, Delabie J, Connors JM, Lansdorp PM, Ouyang Q, Lister TA et al. (2004)
   Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells
   N Engl J Med, 351 (21), 2159-69
   PubMed 15548776
3. Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, Ott G, Müller-Hermelink HK, Campo E, Braziel RM, Jaffe ES, Pan Z, Farinha P, Smith LM, Falini B, Banham AH, Rosenwald A, Staudt LM, Connors JM, Armitage JO, Chan WC (2004)
   Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray
   Blood, 103 (1), 275-82
   PubMed 14504078
4. Hauge H, Patzke S, Delabie J, Aasheim HC (2004)
   Characterization of a novel immunoglobulin-like domain containing receptor
   Biochem Biophys Res Commun, 323 (3), 970-8
   PubMed 15381095
5. Iqbal J, Sanger WG, Horsman DE, Rosenwald A, Pickering DL, Dave B, Dave S, Xiao L, Cao K, Zhu Q, Sherman S, Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Ott G, Müller-Hermelink HK, Delabie J, Braziel RM, Jaffe ES, Campo E, Lynch JC, Connors JM, Vose JM, Armitage JO et al. (2004)
   BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma
   Am J Pathol, 165 (1), 159-66
   PubMed 15215171
6. Kersten C, Delabie J, Gaudernack G, Smeland EB, Fosså A (2004)
   Analysis of the autoantibody repertoire in Burkitt's lymphoma patients: frequent response against the transcription factor ATF-2
   Cancer Immunol Immunother, 53 (12), 1119-26
   PubMed 15185015
7. Rimsza LM, Roberts RA, Miller TP, Unger JM, LeBlanc M, Braziel RM, Weisenberger DD, Chan WC, Muller-Hermelink HK, Jaffe ES, Gascoyne RD, Campo E, Fuchs DA, Spier CM, Fisher RI, Delabie J, Rosenwald A, Staudt LM, Grogan TM (2004)
   Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular Profiling Project
   Blood, 103 (11), 4251-8
   PubMed 14976040
8. Shen Y, Iqbal J, Xiao L, Lynch RC, Rosenwald A, Staudt LM, Sherman S, Dybkaer K, Zhou G, Eudy JD, Delabie J, McKeithan TW, Chan WC (2004)
   Distinct gene expression profiles in different B-cell compartments in human peripheral lymphoid organs
   BMC Immunol, 5, 20
   PubMed 15369600
9. Smeland S, Blystad AK, Kvaløy SO, Ikonomou IM, Delabie J, Kvalheim G, Hammerstrøm J, Lauritzsen GF, Holte H (2004)
   Treatment of Burkitt's/Burkitt-like lymphoma in adolescents and adults: a 20-year experience from the Norwegian Radium Hospital with the use of three successive regimens
   Ann Oncol, 15 (7), 1072-8
   PubMed 15205201
10. Trøen G, Nygaard V, Jenssen TK, Ikonomou IM, Tierens A, Matutes E, Gruszka-Westwood A, Catovsky D, Myklebost O, Lauritzsen G, Hovig E, Delabie J (2004)
    Constitutive expression of the AP-1 transcription factors c-jun, junD, junB, and c-fos and the marginal zone B-cell transcription factor Notch2 in splenic marginal zone lymphoma
    J Mol Diagn, 6 (4), 297-307
    PubMed 15507668

Publications 2003

1. Boudová L, Torlakovic E, Delabie J, Reimer P, Pfistner B, Wiedenmann S, Diehl V, Müller-Hermelink HK, Rüdiger T (2003)
   Nodular lymphocyte-predominant Hodgkin lymphoma with nodules resembling T-cell/histiocyte-rich B-cell lymphoma: differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphoma
   Blood, 102 (10), 3753-8
   PubMed 12881319
2. Ikonomou IM, Nesland JM, Schjølseth SA, Heim S, Delabie J (2003)
   Mantle cell lymphoma with Homer-Wright rosettes
   Virchows Arch, 442 (2), 179-82
   PubMed 12596071
3. Rosenwald A, Wright G, Leroy K, Yu X, Gaulard P, Gascoyne RD, Chan WC, Zhao T, Haioun C, Greiner TC, Weisenburger DD, Lynch JC, Vose J, Armitage JO, Smeland EB, Kvaloy S, Holte H, Delabie J, Campo E, Montserrat E, Lopez-Guillermo A, Ott G, Muller-Hermelink HK, Connors JM, Braziel R et al. (2003)
   Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma
   J Exp Med, 198 (6), 851-62
   PubMed 12975453
4. Rosenwald A, Wright G, Wiestner A, Chan WC, Connors JM, Campo E, Gascoyne RD, Grogan TM, Muller-Hermelink HK, Smeland EB, Chiorazzi M, Giltnane JM, Hurt EM, Zhao H, Averett L, Henrickson S, Yang L, Powell J, Wilson WH, Jaffe ES, Simon R, Klausner RD, Montserrat E, Bosch F, Greiner TC et al. (2003)
   The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma
   Cancer Cell, 3 (2), 185-97
   PubMed 12620412
5. Tierens A, Delabie J, Malecka A, Wang J, Gruszka-Westwood A, Catovsky D, Matutes E (2003)
   Splenic marginal zone lymphoma with villous lymphocytes shows on-going immunoglobulin gene mutations
   Am J Pathol, 162 (2), 681-9
   PubMed 12547726

Publications 2002

1. Rosenwald A, Wright G, Chan WC, Connors JM, Campo E, Fisher RI, Gascoyne RD, Muller-Hermelink HK, Smeland EB, Giltnane JM, Hurt EM, Zhao H, Averett L, Yang L, Wilson WH, Jaffe ES, Simon R, Klausner RD, Powell J, Duffey PL, Longo DL, Greiner TC, Weisenburger DD, Sanger WG, Dave BJ et al. (2002)
   The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma
   N Engl J Med, 346 (25), 1937-47
   PubMed 12075054
2. Rüdiger T, Gascoyne RD, Jaffe ES, de Jong D, Delabie J, De Wolf-Peeters C, Poppema S, Xerri L, Gisselbrecht C, Wiedenmann S, Müller-Hermelink HK (2002)
   Workshop on the relationship between nodular lymphocyte predominant Hodgkin's lymphoma and T cell/histiocyte-rich B cell lymphoma
   Ann Oncol, 13 Suppl 1, 44-51
   PubMed 12078902
3. Torlakovic E, Torlakovic G, Nguyen PL, Brunning RD, Delabie J (2002)
   The value of anti-pax-5 immunostaining in routinely fixed and paraffin-embedded sections: a novel pan pre-B and B-cell marker
   Am J Surg Pathol, 26 (10), 1343-50
   PubMed 12360049
4. Wang J, Delabie J, Aasheim H, Smeland E, Myklebost O (2002)
   Clustering of the SOM easily reveals distinct gene expression patterns: results of a reanalysis of lymphoma study
   BMC Bioinformatics, 3, 36
   PubMed 12445336
5. Aamot H, Micci F, Holte H, Delabie J, Heim S (2002)
   M-FISH cytogenetic analysis of non-Hodgkin lymphomas with t(14;18)(q32;q21) and add(1)(p36) as a secondary abnormality shows that the extra material often comes from chromosome arm 17q
   Leuk Lymphoma, 43 (5), 1051-6
   PubMed 12148885

Publications 2001

1. Blystad AK, Enblad G, Kvaløy S, Berglund A, Delabie J, Holte H, Carlson K, Kvalheim G, Bengtsson M, Hagberg H (2001)
   High-dose therapy with autologous stem cell transplantation in patients with peripheral T cell lymphomas
   Bone Marrow Transplant, 27 (7), 711-6
   PubMed 11360110
2. Blystad AK, Holte H, Kvaløy S, Smeland E, Delabie J, Kvalheim G (2001)
   High-dose therapy in patients with Hodgkin's disease: the use of selected CD34(+) cells is as safe as unmanipulated peripheral blood progenitor cells
   Bone Marrow Transplant, 28 (9), 849-57
   PubMed 11781645
3. Franke S, Wlodarska I, Maes B, Vandenberghe P, Delabie J, Hagemeijer A, De Wolf-Peeters C (2001)
   Lymphocyte predominance Hodgkin disease is characterized by recurrent genomic imbalances
   Blood, 97 (6), 1845-53
   PubMed 11238128
4. Stokke T, DeAngelis P, Smedshammer L, Galteland E, Steen HB, Smeland EB, Delabie J, Holte H (2001)
   Loss of chromosome 11q21-23.1 and 17p and gain of chromosome 6p are independent prognostic indicators in B-cell non-Hodgkin's lymphoma
   Br J Cancer, 85 (12), 1900-13
   PubMed 11747333
5. Torlakovic E, Tierens A, Dang HD, Delabie J (2001)
   The transcription factor PU.1, necessary for B-cell development is expressed in lymphocyte predominance, but not classical Hodgkin's disease
   Am J Pathol, 159 (5), 1807-14
   PubMed 11696441
6. van den Oord JJ, Delabie J (2001)
   Binding of rabbit immunoglobulins to melanoma cells: a pitfall in the immunohistochemical study of malignant melanoma
   Virchows Arch, 438 (4), 421-3
   PubMed 11355181

Publications 2000

1. Meeus G, Ponette J, Delabie J, Verschakelen J, Blockmans D (2000)
   Immunoglobulin related amyloidosis presenting as isolated lymph node and pulmonary involvement
   Leuk Lymphoma, 38 (3-4), 423-7
   PubMed 10830751
2. Tierens A, Delabie J, De Wolf-Peeters C (2000)
   Monocytoid B cells
   Blood, 96 (4), 1612-4
   PubMed 10979665

Publications 1999

1. Driessen A, Ectors N, Van Cutsem E, Penninckx F, Filez L, Pittaluga S, Delabie J, De Wolf-Peeters C, Geboes K (1999)
   Different gastritis features are linked to different gastric neoplasms
   Gastroenterol Clin Biol, 23 (6-7), 747-53
   PubMed 10470530
2. Driessen A, Tierens A, Ectors N, Stul M, Pittaluga S, Geboes K, Delabie J, De Wolf-Peeters C (1999)
   Primary diffuse large B cell lymphoma of the stomach: analysis of somatic mutations in the rearranged immunoglobulin heavy chain variable genes indicates antigen selection
   Leukemia, 13 (7), 1085-92
   PubMed 10400425
3. Mulier S, Stas M, Delabie J, Lateur L, Gysen M, Dal Cin P, Robberecht C, De Wever I (1999)
   Proliferative myositis in a child
   Skeletal Radiol, 28 (12), 703-9
   PubMed 10653366
4. Pittaluga S, Tierens A, Dodoo YL, Delabie J, De Wolf-Peeters C (1999)
   How reliable is histologic examination of bone marrow trephine biopsy specimens for the staging of non-Hodgkin lymphoma? A study of hairy cell leukemia and mantle cell lymphoma involvement of the bone marrow trephine specimen by histologic, immunohistochemical, and polymerase chain reaction techniques
   Am J Clin Pathol, 111 (2), 179-84
   PubMed 9930138
5. Tierens A, Delabie J, Michiels L, Vandenberghe P, De Wolf-Peeters C (1999)
   Marginal-zone B cells in the human lymph node and spleen show somatic hypermutations and display clonal expansion
   Blood, 93 (1), 226-34
   PubMed 9864165
6. van der Werff ten Bosch J, Delabie J, Böhler T, Verschuere J, Thielemans K (1999)
   Revision of the diagnosis of T-zone lymphoma in the father of a patient with autoimmune lymphoproliferative syndrome type II
   Br J Haematol, 106 (4), 1045-8
   PubMed 10520011

Publications 1998

1. Michiels L, Van Leuven F, van den Oord JJ, De Wolf-Peeters C, Delabie J (1998)
   Representational difference analysis using minute quantities of DNA
   Nucleic Acids Res, 26 (15), 3608-10
   PubMed 9671826
2. Pittaluga S, Tierens A, Pinyol M, Campo E, Delabie J, De Wolf-Peeters C (1998)
   Blastic variant of mantle cell lymphoma shows a heterogenous pattern of somatic mutations of the rearranged immunoglobulin heavy chain variable genes
   Br J Haematol, 102 (5), 1301-6
   PubMed 9753060
3. Tierens A, Delabie J, Pittaluga S, Driessen A, DeWolf-Peeters C (1998)
   Mutation analysis of the rearranged immunoglobulin heavy chain genes of marginal zone cell lymphomas indicates an origin from different marginal zone B lymphocyte subsets
   Blood, 91 (7), 2381-6
   PubMed 9516137
4. Van Leuven F, Torrekens S, Moechars D, Hilliker C, Buellens M, Bollen M, Delabie J (1998)
   Molecular cloning of a gene on chromosome 19q12 coding for a novel intracellular protein: analysis of expression in human and mouse tissues and in human tumor cells, particularly Reed-Sternberg cells in Hodgkin disease
   Genomics, 54 (3), 511-20
   PubMed 9878255
5. Vandenborre K, Delabie J, Boogaerts MA, De Vos R, Lorré K, De Wolf-Peeters C, Vandenberghe P (1998)
   Human CTLA-4 is expressed in situ on T lymphocytes in germinal centers, in cutaneous graft-versus-host disease, and in Hodgkin's disease
   Am J Pathol, 152 (4), 963-73
   PubMed 9546357

Publications 1997

1. d'Amore F, Stribley JA, Ohno T, Wu G, Wickert RS, Delabie J, Hinrichs SH, Chan WC (1997)
   Molecular studies on single cells harvested by micromanipulation from archival tissue sections previously stained by immunohistochemistry or nonisotopic in situ hybridization
   Lab Invest, 76 (2), 219-24
   PubMed 9042158
2. Maes M, Depardieu C, Dargent JL, Hermans M, Verhaeghe JL, Delabie J, Pittaluga S, Troufléau P, Verhest A, De Wolf-Peeters C (1997)
   Primary low-grade B-cell lymphoma of MALT-type occurring in the liver: a study of two cases
   J Hepatol, 27 (5), 922-7
   PubMed 9382982
3. Van Gool SW, Delabie J, Vandenberghe P, Coorevits L, De Wolf-Peeters C, Ceuppens JL (1997)
   Expression of B7-2 (CD86) molecules by Reed-Sternberg cells of Hodgkin's disease
   Leukemia, 11 (6), 846-51
   PubMed 9177439

Publications 1996

1. Chan WC, Delabie J (1996)
   Single cell analysis of H/RS cells
   Ann Oncol, 7 Suppl 4, 41-3
   PubMed 8836408
2. Delabie J, Greiner TC, Chan WC, Weisenburger DD (1996)
   Concurrent lymphocyte predominance Hodgkin's disease and T-cell lymphoma. A report of three cases
   Am J Surg Pathol, 20 (3), 355-62
   PubMed 8772790
3. Delabie J, Tierens A, Gavriil T, Wu G, Weisenburger DD, Chan WC (1996)
   Phenotype, genotype and clonality of Reed-Sternberg cells in nodular sclerosis Hodgkin's disease: results of a single-cell study
   Br J Haematol, 94 (1), 198-205
   PubMed 8757535

Publications 1995

1. Chan WC, Delabie J (1995)
   Hodgkin's disease. Lineage and clonality
   Am J Clin Pathol, 104 (4), 368-70
   PubMed 7572783
2. Delabie J, Chan WC, Weisenburger DD, De Wolf-Peeters C (1995)
   The antigen-presenting cell function of Reed-Sternberg cells
   Leuk Lymphoma, 18 (1-2), 35-40
   PubMed 8580827
3. Delabie J, Weisenburger DD, Chan WC (1995)
   Hodgkin's disease: a monoclonal lymphoproliferative disorder?
   Histopathology, 27 (1), 93-6
   PubMed 7557916

Publications 1994

1. Dal Cin P, Sciot R, Aly MS, Delabie J, Stas M, De Wever I, Van Damme B, Van den Berghe H (1994)
   Some desmoid tumors are characterized by trisomy 8
   Genes Chromosomes Cancer, 10 (2), 131-5
   PubMed 7520266
2. Delabie J, Tierens A, Wu G, Weisenburger DD, Chan WC (1994)
   Lymphocyte predominance Hodgkin's disease: lineage and clonality determination using a single-cell assay
   Blood, 84 (10), 3291-8
   PubMed 7949084
3. Hilliker C, Delabie J, Speleman F, Bilbe G, Bruggen J, Van Leuven F, Van den Berghe H (1994)
   Localization of the gene (RSN) coding for restin, a marker for Reed-Sternberg cells in Hodgkin's disease, to human chromosome band 12q24.3 and YAC cloning of the locus
   Cytogenet Cell Genet, 65 (3), 172-6
   PubMed 8222754
4. Lorent K, Overbergh L, Delabie J, Van Leuven F, Van den Berghe H (1994)
   Distribution of mRNA coding for alpha-2-macroglobulin, the murinoglobulins, the alpha-2-macroglobulin receptor and the alpha-2-macroglobulin receptor associated protein during mouse embryogenesis and in adult tissues
   Differentiation, 55 (3), 213-23
   PubMed 7514554

Publications 1993

1. De Wolf-Peeters C, Delabie J (1993)
   Anatomy and histophysiology of lymphoid tissue
   Semin Oncol, 20 (6), 555-69
   PubMed 8296195
2. Delabie J, Bilbe G, Brüggen J, Van Leuven F, De Wolf-Peeters C (1993)
   Restin in Hodgkin's disease and anaplastic large cell lymphoma
   Leuk Lymphoma, 12 (1-2), 21-6
   PubMed 8161933
3. Delabie J, Ceuppens JL, Vandenberghe P, de Boer M, Coorevits L, De Wolf-Peeters C (1993)
   The B7/BB1 antigen is expressed by Reed-Sternberg cells of Hodgkin's disease and contributes to the stimulating capacity of Hodgkin's disease-derived cell lines
   Blood, 82 (9), 2845-52
   PubMed 7693051
4. Vandenberghe E, Van Hove J, Brock P, Schmidt P, Delabie J, Casteels-Van Daele M, Cassiman JJ, Vanderschueren-Lodeweyckx M, Van den Berghe H (1993)
   Non-endemic Burkitt's lymphoma in a patient with Bloom's syndrome
   Leuk Lymphoma, 10 (4-5), 377-82
   PubMed 8220137
5. Vandenberghe P, Delabie J, de Boer M, De Wolf-Peeters C, Ceuppens JL (1993)
   In situ expression of B7/BB1 on antigen-presenting cells and activated B cells: an immunohistochemical study
   Int Immunol, 5 (3), 317-21
   PubMed 7682106
6. Wlodarska I, Delabie J, De Wolf-Peeters C, Mecucci C, Stul M, Verhoef G, Cassiman JJ, Van den Berghe H (1993)
   T-cell lymphoma developing in Hodgkin's disease: evidence for two clones
   J Pathol, 170 (3), 239-48
   PubMed 8133397

Publications 1992

1. Bilbe G, Delabie J, Brüggen J, Richener H, Asselbergs FA, Cerletti N, Sorg C, Odink K, Tarcsay L, Wiesendanger W (1992)
   Restin: a novel intermediate filament-associated protein highly expressed in the Reed-Sternberg cells of Hodgkin's disease
   EMBO J, 11 (6), 2103-13
   PubMed 1600942
2. Dal Cin P, Aly MS, Delabie J, Ceuppens JL, Van Gool S, Van Damme B, Baert L, Van Poppel H, Van den Berghe H (1992)
   Trisomy 7 and trisomy 10 characterize subpopulations of tumor-infiltrating lymphocytes in kidney tumors and in the surrounding kidney tissue
   Proc Natl Acad Sci U S A, 89 (20), 9744-8
   PubMed 1409692
3. Delabie J, De Wolf-Peeters C (1992)
   Human immunodeficiency virus-associated Hodgkin's disease
   Cancer, 69 (2), 601
   PubMed 1728393
4. Delabie J, Shipman R, Brüggen J, De Strooper B, van Leuven F, Tarcsay L, Cerletti N, Odink K, Diehl V, Bilbe G (1992)
   Expression of the novel intermediate filament-associated protein restin in Hodgkin's disease and anaplastic large-cell lymphoma
   Blood, 80 (11), 2891-6
   PubMed 1450414
5. Delabie J, Vandenberghe E, Kennes C, Verhoef G, Foschini MP, Stul M, Cassiman JJ, De Wolf-Peeters C (1992)
   Histiocyte-rich B-cell lymphoma. A distinct clinicopathologic entity possibly related to lymphocyte predominant Hodgkin's disease, paragranuloma subtype
   Am J Surg Pathol, 16 (1), 37-48
   PubMed 1728195
6. Morren M, Van Lierde S, Lacquet F, Ceuppens JL, Delabie J, Dewolf-Peeters C, Degreef H (1992)
   A case of Omenn-like immunodeficiency syndrome
   Dermatology, 185 (4), 302-4
   PubMed 1477428
7. Morren MA, Dooms-Goossens A, Delabie J, De Wolf-Peeters C, Marien K, Degreef H (1992)
   Contact allergy to isothiazolinone derivatives: unusual clinical presentations
   Dermatology, 184 (4), 260-4
   PubMed 1498392

Publications 1991

1. Delabie J, De Wolf-Peeters C (1991)
   Nuclear segmentation anomalies of neutrophils in neutrophilic dermatosis associated with myelodysplastic syndrome
   J Am Acad Dermatol, 24 (6 Pt 1), 1037-8
   PubMed 1869678
2. Delabie J, De Wolf-Peeters C, Bobbaers H, Bilbe G, Desmet VJ (1991)
   Immunophenotypic analysis of histiocytes involved in AIDS-associated Mycobacterium scrofulaceum infection: similarities with lepromatous lepra
   Clin Exp Immunol, 85 (2), 214-8
   PubMed 1864000
3. Delabie J, De Wolf-Peeters C, De Vos R, Vandenberghe E, Kennes K, De Jonge I, Desmet V (1991)
   True histiocytic neoplasm of Langerhans' cell type
   J Pathol, 163 (3), 217-23
   PubMed 1707450
4. Delabie J, De Wolf-Peeters C, Mooren M, Karien K, Roskams T, Desmet V (1991)
   Histiocytes in Sweet's syndrome
   Br J Dermatol, 124 (4), 348-53
   PubMed 2025555
5. Vandenberghe E, de Wolf-Peeters C, Delabie J, Thomas J, Michaux JL, Noël H, Mecucci C, Van Den Berghe H (1991)
   Cytogenetic characterization of three cases of unusual B-cell non-Hodgkin's lymphoma
   Cancer Genet Cytogenet, 53 (2), 229-35
   PubMed 2065296
6. Vandenberghe E, De Wolf-Peeters C, van den Oord J, Wlodarska I, Delabie J, Stul M, Thomas J, Michaux JL, Mecucci C, Cassiman JJ (1991)
   Translocation (11;14): a cytogenetic anomaly associated with B-cell lymphomas of non-follicle centre cell lineage
   J Pathol, 163 (1), 13-8
   PubMed 2002419

Publications 1990

1. Delabie J, De Wolf-Peeters C, Cappelle L, Van Damme B, Desmet V (1990)
   Branchial cleftlike cysts of the thyroid
   Am J Surg Pathol, 14 (12), 1165-7
   PubMed 2078246
2. Delabie J, de Wolf-Peeters C, van den Oord JJ, Desmet VJ (1990)
   Differential expression of the calcium-binding proteins MRP8 and MRP14 in granulomatous conditions: an immunohistochemical study
   Clin Exp Immunol, 81 (1), 123-6
   PubMed 2199095
3. van den Oord JJ, De Vos R, Facchetti F, Delabie J, De Wolf-Peeters C, Desmet VJ (1990)
   Distribution of non-lymphoid, inflammatory cells in chronic HBV infection
   J Pathol, 160 (3), 223-30
   PubMed 2139889
4. van den Oord JJ, Facchetti F, Delabie J, de Wolf-Peeters C (1990)
   T lymphocytes in non-neoplastic lymph nodes
   Curr Top Pathol, 84 ( Pt 1), 149-78
   PubMed 2292192

Publications 1989

1. Geboes K, Delabie J, Rutgeerts P, Vantrappen G (1989)
   Endoscopy as a diagnostic tool in inflammatory bowel disease
   Acta Chir Belg, 89 (2), 106-10
   PubMed 2756804